Search Results
ROXANE: impact of 21-gene assay on treatment for early breast cancer
Assessing the Role of 21-Gene Assays in Breast Cancer
TAILORx: Phase 3 trial validating a 21-gene expression assay in breast cancer
Dr. Brufsky on Genomic Assays for Breast Cancer
Importance of biomarkers when evaluating heterogeneity in HER2+ metastatic BC
Towards Spatially Resolved Single Cell Atlases of Tumor Initiation
CRISPR Explained
Spatial Data Analyses and AI Models for Cancer Research
Breast cancer at 21
Anaplastic Large Cell Lymphoma (BIA-ALCL) with Special Guest Roxanne Who Was Diagnosed Stage 4.
CSHL Keynote, Dr, Richard Young, Whitehead Institute/M.I.T.
Anthony Estrada, Med Chem Marksman